A Study of MEDI-575 in Patients With Advanced Solid Malignancies

NCT01102400 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Malignancies

Interventions

DRUG: MEDI-575

Sponsor

AstraZeneca

Collaborators

[object Object]